Skip to content
Open access · CC-BY via OpenAlex

NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay

Simona Cernea

Life · 2024 · ▲ 26 citations

Abstract

The bidirectional relationship between type 2 diabetes and (non-alcoholic fatty liver disease) NAFLD is indicated by the higher prevalence and worse disease course of one condition in the presence of the other, but also by apparent beneficial effects observed in one, when the other is improved. This is partly explained by their belonging to a multisystemic disease that includes components of the metabolic syndrome and shared pathogenetic mechanisms. Throughout the progression of NAFLD to more advanced stages, complex systemic and local metabolic derangements are involved. During fibrogenesis, a significant metabolic reprogramming occurs in the hepatic stellate cells, hepatocytes, and immune cells, engaging carbohydrate and lipid pathways to support the high-energy-requiring processes. The natural history of NAFLD evolves in a variable and dynamic manner, probably due to the interaction of a variable number of modifiable (diet, physical exercise, microbiota composition, etc.) and non-modifiable (genetics, age, ethnicity, etc.) risk factors that may intervene concomitantly, or subsequently/intermittently in time. This may influence the risk (and rate) of fibrosis progression/regression. The recognition and control of the factors that determine a rapid progression of fibrosis (or its regression) are critical, as the fibrosis stages are associated with the risk of liver-related and all-cause mortality.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/life14020272
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Cernea, S. (2024). NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. <em>Life</em>. https://doi.org/10.3390/life14020272
Vancouver
Cernea S. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life. 2024. doi:10.3390/life14020272.
BibTeX
@article{simona2024NAFLDF, title = {NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay}, author = {Simona Cernea}, journal = {Life}, year = {2024}, doi = {10.3390/life14020272}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings